ISOL.F Stock Overview
Engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Isodiol International Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | -99.98% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ISOL.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 3.4% | 1.6% |
| 1Y | 0% | 14.2% | 32.3% |
Return vs Industry: ISOL.F underperformed the US Pharmaceuticals industry which returned 13.7% over the past year.
Return vs Market: ISOL.F underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| ISOL.F volatility | |
|---|---|
| ISOL.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ISOL.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine ISOL.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Marcos Agramont | isodiol.com |
Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products.
Isodiol International Inc. Fundamentals Summary
| ISOL.F fundamental statistics | |
|---|---|
| Market cap | US$128.00 |
| Earnings (TTM) | -US$69.70m |
| Revenue (TTM) | US$11.26m |
0.0x
P/S Ratio0.0x
P/E RatioIs ISOL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ISOL.F income statement (TTM) | |
|---|---|
| Revenue | CA$15.79m |
| Cost of Revenue | CA$12.81m |
| Gross Profit | CA$2.98m |
| Other Expenses | CA$100.74m |
| Earnings | -CA$97.76m |
Last Reported Earnings
Dec 31, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ISOL.F perform over the long term?
See historical performance and comparison